Definitive Contract HT942523C0017
- Not listed
- The U.S. Army's TACOM Life Cycle Management Command awarded a $992,552.36 cost-plus-fixed-fee contract to Innovital Systems Inc., a small business based in Calverton, Maryland. This Phase II Small Business Innovation Research (SBIR) contract is for the continued development of various medical devices and technologies for military applications, including a next-generation nasopharyngeal airway, a casualty transport pad, and a semi-autonomous device for blind endotracheal intubation. Innovital...
- This is a $1,408,729.79 firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Innovital Systems Inc., a small business, for a Phase I Small Business Innovation Research (SBIR) program project. The contract supports research and development of medical devices, such as a next-generation nasopharyngeal airway and a casualty transport pad with antiseptic, warming, and pressure-relieving properties. Innovital Systems has a track record of federal contracts and grants,...
- This federal contract award, W81XWH16C0180, was made by the U.S. Army Medical Command (MEDCOM) to Innovital Systems Inc., a small business, for a Phase I Small Business Innovation Research (SBIR) project. The contract is a firm fixed-price definitive contract with a ceiling value of $149,943 and a completion date of December 31, 2017. Innovital Systems is an advanced technology company specializing in biomedical engineering, product development, and research services for federal agencies. This...
- This is a $527,248.20 cost-plus-fixed-fee delivery order contract awarded to Innovital Systems Inc., a small, for-profit advanced technology company specializing in biomedical engineering and research services. The contract was awarded by the Naval Air Warfare Center, a defense agency, to complete the PVASS NRE-QUAL COMPLETION and REGENERATE efforts. Innovital Systems has a strong reputation for developing innovative medical technologies and engineering solutions for federal agencies through the...
- This is a $997,828.73 SBIR Phase II contract awarded by the Defense Health Agency to Innovital Systems Inc., a small business prime contractor, for the development of an intravenous/intubation pilot device to facilitate vascular access. The contract was set aside for small businesses. Innovital Systems is an advanced technology company that has delivered various goods and services to Department of Defense agencies through prime and subcontractor roles, including medical research and development,...
- Innovital Systems Inc. has been awarded a definitive contract valued at $1,099,906.57 by the Defense Health Agency to conduct medical research and development under Phase II of the Small Business Innovation Research program. The contract involves Innovital's SURETUBE technology, a semi-autonomous device to assist with blind endotracheal intubation. Work will be performed in Calverton, Maryland over a three-year period concluding in May 2024. The firm fixed price contract has been set aside for...
- The U.S. Army Medical Command awarded a $149,988.40 Firm Fixed Price contract to Innovital Systems Inc., a small business, for Phase I research and development of a "SURETUBE: A MAGNET-ASSISTED, SEMI-AUTONOMOUS APPROACH TO BLIND ENDOTRACHEAL INTUBATION" under the Small Business Innovation Research (SBIR) program. The contract was awarded on September 1, 2016, with a targeted completion date of January 23, 2018. Innovital Systems is an advanced technology company with expertise in...
- This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Department of the Army Medical Command to Innovital Systems Inc., a for-profit small business organization. The contract, valued at $998,010.41, is for the development of innovative products and services in the defense, aerospace, and biomedical markets. Innovital Systems has a history of federal contract work, including providing research, engineering services, prototype devices, and specialty equipment to...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Innovital Systems Inc., a for-profit small business organization. The contract has a firm fixed price of $149,961.43 and is focused on research and development related to the SBIR program. As a prime contractor, Innovital Systems has received over $7 million in federal contracts since 2019 to deliver a range of goods and services to the Department of Defense, including...
- This is a $149,972.30 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Innovital Systems Inc., a small business specializing in biomedical engineering and research services. The contract, designated as a total small business set-aside, is for a SBIR proposal titled "SBIR DHP PHASE 1 PROPOSAL H161-011-0121" and has an ultimate completion date of April 29, 2017. Innovital Systems has a strong track record of securing SBIR...
The U.S. Medical Command has awarded a Small Business Innovation Research (SBIR) Phase II contract to Innovital Systems Inc., a small business technology company, for the development of a "Next-Generation Nasopharyngeal Airway." The contract is a Firm Fixed Price definitive contract with a ceiling value of $1,099,929.98 and a period of performance ending on March 31, 2026. This SBIR Phase II award was set aside for small businesses. Innovital Systems Inc. is an advanced technology company with expertise in biomedical engineering, product development, and research services for federal agencies, particularly the Department of Defense and NASA. The company has a strong track record of securing SBIR awards and delivering innovative solutions in medical devices, survivability engineering, and sensor technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 2/25/25 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 9/3/24 | |
| Not listed | Not listed | $1.1m | 2/7/23 |